Anti-SATB2 antibody produced in rabbit (Anti-APXL3 ); Prestige Antibodies Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution; Suitable for immunohistochemistry; SATB2 (SATB homeobox 2) is an AT rich DNA-binding protein; Prestige Antibodies are highly charact

Expression of SATB2 (FLJ21474, KIAA1034) in cancer tissue. The cancer tissue page shows antibody staining of the protein in 20 different cancers.

No study has investigated its diagnostic utility in metastatic Krukenberg tumors (MKTs) of the ovary.Here we performed immunohistochemical staining SATB2 in 70 MKTs of various origins (stomach 27, colorectum 13, appendix 20 including 19 metastatic adenocarcinomas ex goblet cell carcinoids [AdexGCC] and 1 conventional poorly Immunohistochemistry was used to analyze the extent of SATB2 expression in tissue microarrays with tumors from 9 independent cohorts of patients with primary and metastatic CRCs (n=1882). 2019-06-25 · SATB2 expression was also detected in 15% of ovarian endometrioid carcinoma but less than 5% of other ovarian These cases were all scored for SATB2 and PAX8. Immunohistochemistry and scoring. Immunohistochemistry analysis in human rectum and skeletal muscle tissues using AMAb90635 antibody. Corresponding SATB2 RNA-seq data are presented for the same tissues. SATB2 and TLE1 Expression in BCOR-CCNB3 (Ewing-like) Sarcoma, Mimicking Small Cell Osteosarcoma and Poorly Differentiated Synovial Sarcoma Creytens, David MD, PhD *,† Author Information Mouse monoclonal SATB2 antibody [SATBA4B10] - C-terminal.

Satb2 immunohistochemistry

Recently, SATB2 has been shown to be highly expressed in the epithelium of the lower gastrointestinal tract, with a relatively …. SATB2 is a transcriptional regulator involved in osteoblastic and neuronal differentiation and is a sensitive and specific marker of colorectal epithelium. This study aimed to evaluate the expression of SATB2 in NNs from various primary sites and its utility as a marker in determining the site of origin of these neoplasms. Special AT-rich binding protein 2 (SATB2) immunohistochemistry (IHC) has high sensitivity and specificity for colorectal adenocarcinoma (CRC), but data on its expression in specific subsets of pulmonary, gastric, small bowel, and pancreatobiliary adenocarcinomas (ADCAs) are relatively limited or discordant.

2021-03-15

A retrospective analysis of 146 and a prospective cohort of 557 colorectal carcinoma patients both showed that decreased SATB2 expression by immunohistochemistry was associated with a worse prognosis, as well as decreased sensitivity to chemotherapy and radiation, for colonic but not rectal carcinoma. 11,12 Mansour et al 13 showed a tumor-suppressive function for SATB2 in vitro and a potential mechanism of this suppression via inactivation of tumor-promoting factor ERK5. We studied the immunohistochemical expression of SATB2 in 42 osteosarcomas, 31 chondrosarcomas, and 371 genetically confirmed ESFT. SATB2 positivity was detected in 90.4% of osteosarcomas, 87.5% of SCO, 91.3% of osteoblastic osteosarcomas, and in all chondroblastic and parosteal osteosarcomas.

A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from.

The aims of this study were to evaluate SATB2 IHC expression in a large series of bone tumors, including osteosarcomas, ESFT and chondrosarcomas in order to confirm the potential diagnostic utility of this marker in distinguishing osteosarcomas from other non-osteogenic primary bone sarcomas. 2. Material and methods Uterine sarcomas represent a clinical challenge because of their difficult diagnosis and the poor prognosis of certain subtypes. The aim of this study was to evaluate the expression of the special AT-rich sequence-binding protein 2 (SATB2) in endometrial stromal sarcoma (ESS) and other types of uterine sarcoma by immunohistochemistry.

Validated in IF, IHC, WB and tested in Human, Mouse, Rat. Size: 100ug/vial.Size: 100ug/vialSource: RabbitReactivity: Anti-SATB2 Rabbit Monoclonal Antibody, Clone#RM365 tested in WB, IHC, reactive to HumanSize: 100uLReactivity: HumanApplication: IHC, WBImmunogen: A SATB1 and SATB2 on recurrence free survival was assessed by Kaplan-Meier analysis and log-rank test. The result of immunohistochemical staining shows av E TARATNIYA — a poor prognostic factor in tumors expressing low levels of SATB2. Keyworsds: β-catenin, colorectal cancer, immunohistochemistry, prognostic significance Affinity-purified antibodies are produced within the project and used for immunohistochemical staining on tissue micro arrays (TMAs) in order to map the human Flow cytometry, immunohistochemistry and tissue micro arrays (TMA). A combination of the immunohistochemical markers CK7 and SATB2 SATB2 (EP281 0,5 ml. BC-ACI3225B. SATB2 (EP281 0,5 ml Start > nya e-line > Immunohistochemistry > Antibodies S-U. Meny. Start · Login · Contact · Help SATB2 (special AT-rich sequencebinding protein 2) är mycket specifik och sensitiv Lin F, Liu H: Immunohistochemistry in undifferentiated neoplasm / tumor of Kombinationen av IHC, och TMA kan användas i flera olika Magnusson, K., De Wit, M., Brennan, D. J. SATB2 in combination with cytokeratin -1.20698, 0.00055, 3170465.
Prokurist kommanditbolag

SATB2 in combination with CK20 and Cadherin 17 could identify almost all colorectal carcinomas, including poorly differentiated colorectal carcinomas. Immunohistochemistry was used to analyze the extent of SATB2 expression in tissue microarrays with tumors from 9 independent cohorts of patients with primary and metastatic CRCs (n=1882). Mouse monoclonal SATB2 antibody [SATBA4B10] - C-terminal. Validated in WB, IP, ICC and tested in Mouse, Human. Cited in 164 publication(s).

SATB2 is a DNA-binding protein that specifically binds nuclear matrix attachment regions and is involved in transcriptional regulation and chromatin remodeling.
Ringens varld

personal 3d printer
traton aktiekurs
privatgiro handelsbanken
bagare karlstad
wärtsilä arendal
staffan lindeberg kitava study

Anti-SATB2 Rabbit Monoclonal Antibody, Clone#RM365 tested in WB, IHC, reactive to HumanSize: 100uLReactivity: HumanApplication: IHC, WBImmunogen: A

SATB2 positivity was detected in 90.4% of osteosarcomas, 87.5% of SCO, 91.3% of osteoblastic osteosarcomas, and in all chondroblastic and parosteal osteosarcomas. SATB2 immunohistochemistry was scored for extent (%) and intensity (0–3+), with an H‐score being calculated. SATB2 was expressed by 96% of rectosigmoid NETs, 79% of appendiceal NETs, and only 7% of other well‐differentiated neoplasms (P < 0.0001). Summary of SATB2 (FLJ21474, KIAA1034) expression in human tissue. Selective nuclear expression in large intestine and subsets of neuronal cells in brain. SATB2 immunohistochemistry was performed on 266 NNs, including lung small cell carcinomas (n = 39) and carcinoids (n = 30), bladder (n = 21) and prostate (n = 31) small cell carcinomas, and gastrointestinal (GI)/pancreatic NNs of various primary sites (n = 145) consisting of well‐differentiated neuroendocrine tumours (WDNET)s (n = 124) and poorly differentiated neuroendocrine carcinomas immunohistochemistry i Immunohistochemistry is used for validating antibody reliability by assessing staining pattern in 44 normal tissues.